Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 22759679)

1.

Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study report.

Minafra L, Norata R, Bravatà V, Viola M, Lupo C, Gelfi C, Messa C.

BMC Res Notes. 2012 Jul 3;5:343. doi: 10.1186/1756-0500-5-343.

2.

Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.

Soon PS, Kim E, Pon CK, Gill AJ, Moore K, Spillane AJ, Benn DE, Baxter RC.

Endocr Relat Cancer. 2013 Jan 7;20(1):1-12. doi: 10.1530/ERC-12-0227. Print 2013 Feb.

3.

Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.

Makdissi FB, Machado LV, Oliveira AG, Benvenuti TT, Katayama ML, Brentani MM, Osório CA, Mourão Netto M, Lyra EC, Carvalho F, Góes JC, Folgueira MA.

Braz J Med Biol Res. 2009 Dec;42(12):1128-37. Epub 2009 Nov 6.

4.

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ.

Breast Cancer Res Treat. 2010 Nov;124(2):317-26. doi: 10.1007/s10549-010-0734-1. Epub 2010 Jan 20.

PMID:
20087650
5.

Gene expression profiling of epithelial-mesenchymal transition in primary breast cancer cell culture.

Minafra L, Bravatà V, Forte GI, Cammarata FP, Gilardi MC, Messa C.

Anticancer Res. 2014 May;34(5):2173-83.

PMID:
24778019
6.

p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.

Megha T, Ferrari F, Benvenuto A, Bellan C, Lalinga AV, Lazzi S, Bartolommei S, Cevenini G, Leoncini L, Tosi P.

J Clin Pathol. 2002 Jun;55(6):461-6.

7.

Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells.

Nishikata T, Ishikawa M, Matsuyama T, Takamatsu K, Fukuhara T, Konishi Y.

Anticancer Res. 2013 Jul;33(7):2867-73.

PMID:
23780972
8.

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.

PMID:
16244790
9.

Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.

Lapyckyj L, Castillo LF, Matos ML, Gabrielli NM, Lüthy IA, Vazquez-Levin MH.

J Cell Physiol. 2010 Mar;222(3):596-605. doi: 10.1002/jcp.21974.

PMID:
19957299
10.

Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.

Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z, Fan Y, Chen X, Wu C.

Mol Cell Biochem. 2012 Apr;363(1-2):427-36. doi: 10.1007/s11010-011-1195-5. Epub 2011 Dec 21.

PMID:
22187223
11.

[Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].

Wu WX, Zhang YP, Wen XW, Lu N, Tang ZY, Zhang Y, Wang Z, Wang W, Yang HJ.

Zhonghua Bing Li Xue Za Zhi. 2009 Aug;38(8):519-23. Chinese.

PMID:
20021961
12.

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.

Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C.

PLoS One. 2012;7(6):e39520. doi: 10.1371/journal.pone.0039520. Epub 2012 Jun 25.

13.

Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.

Liu T, Zhang X, Shang M, Zhang Y, Xia B, Niu M, Liu Y, Pang D.

J Surg Oncol. 2013 Feb;107(2):188-94. doi: 10.1002/jso.23240. Epub 2012 Aug 8.

PMID:
22886823
14.

Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.

Mackinder MA, Evans CA, Chowdry J, Staton CA, Corfe BM.

Cancer Biomark. 2012;12(2):49-64. doi: 10.3233/CBM-120293.

PMID:
23396250
15.

Observed changes in the morphology and phenotype of breast cancer cells in direct co-culture with adipose-derived stem cells.

Kuhbier JW, Bucan V, Reimers K, Strauss S, Lazaridis A, Jahn S, Radtke C, Vogt PM.

Plast Reconstr Surg. 2014 Sep;134(3):414-23. doi: 10.1097/PRS.0000000000000525.

PMID:
25158701
16.

Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.

Li S, Xu H, Ding H, Huang Y, Cao X, Yang G, Li J, Xie Z, Meng Y, Li X, Zhao Q, Shen B, Shao N.

J Pathol. 2009 Jul;218(3):327-36. doi: 10.1002/path.2543.

PMID:
19291713
17.

Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF-10F cells.

Higgy NA, Salicioni AM, Russo IH, Zhang PL, Russo J.

Mol Carcinog. 1997 Dec;20(4):332-9.

PMID:
9433477
18.

Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.

Corradini P, Voena C, Astolfi M, Delloro S, Pilotti S, Arrigoni G, Bregni M, Pileri A, Gianni AM.

Ann Oncol. 2001 Dec;12(12):1693-8.

19.

MMP13 is potentially a new tumor marker for breast cancer diagnosis.

Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR.

Oncol Rep. 2009 Nov;22(5):1119-27.

PMID:
19787229
20.

In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation.

Perán M, Marchal JA, García MA, Kenyon J, Tosh D.

Cell Oncol (Dordr). 2013 Jul;36(4):289-301. doi: 10.1007/s13402-013-0134-8. Epub 2013 May 16.

PMID:
23677639
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk